Wed, 07/09/2025 - 00:09 |
Survival Disparities Increase for Patients Without Health Insurance Following FDA Approval of Immune Checkpoint Inhibitors for Advanced Cancers, New ACS Study Shows |
American Cancer... |
Wed, 07/09/2025 - 00:05 |
ATLANTA, July 7, 2025 In a new study led by the |
American Cancer... |
Tue, 07/01/2025 - 15:01 |
NYU Tandon engineers create first immunocompetent leukemia device for CAR T immunotherapy screening |
NYU Tandon |
Fri, 06/27/2025 - 18:27 |
Provectus Biopharmaceuticals Announces Publication of Moffitt Cancer Center Research on PV-10 for Head and Neck Cancer |
Provectus Bioph... |
Thu, 06/26/2025 - 02:36 |
80 per cent of colorectal cancers resist immunotherapy. This DNA treatment could help |
University of A... |
Thu, 06/19/2025 - 22:51 |
UW researchers develop personalized cancer vaccines that slow tumor recurrence in mice |
University of W... |
Mon, 06/02/2025 - 11:18 |
Finnish researchers discovery may reveal why breast cancer is not always responsive to immunotherapy |
HelsinkiUniv |
Sun, 06/01/2025 - 18:51 |
Adding Immunotherapy to Standard Treatment Before and After Surgery Helps Gastric and Gastroesophageal Cancer Patients Live Longer Without Cancer Recurrence |
MSKCC |
Thu, 05/15/2025 - 12:31 |
Andy Minn, MD, PhD, will rejoin Memorial Sloan Kettering Cancer Center as the Inaugural Chair of MSKs new Immuno-Oncology Program |
MSKCC |
Mon, 05/12/2025 - 19:39 |
Fox Chase Cancer Center Researcher Secures Funding to Investigate Toxicity Reduction in Bladder Cancer Treatment |
Fox Chase |
Mon, 04/28/2025 - 18:39 |
Immunotherapy before and after surgery improves outcomes in head and neck cancer |
Dana Farber |
Sun, 04/27/2025 - 18:15 |
Adjuvant PD-1 Blockade for Mismatch Repair-deficient Solid Cancers Directed by ctDNA Status Delivers Clinical Benefit |
American Associ... |
Sun, 04/27/2025 - 12:15 |
Adding Perioperative Pembrolizumab to Standard of Care Improves Outcomes in Patients With Newly Diagnosed Head and Neck Cancer |
American Associ... |
Fri, 04/18/2025 - 18:39 |
Some Patients May Experience Durable Disease Control Even After Discontinuing Immune Checkpoint Inhibitors for Side Effects |
American Associ... |
Wed, 04/09/2025 - 16:52 |
Potential Alzheimers disease therapeutic target identified in brain immune cells |
Broad Institute |
Wed, 04/09/2025 - 00:16 |
Bringing New Hope: Dr. Michael Olins Breakthrough Immunotherapy for Brain Tumors |
American Brain ... |
Tue, 04/08/2025 - 15:35 |
Cancer-fighting implant shows promise in treating melanoma, pancreatic and colorectal tumors |
RiceUniv |
Fri, 03/28/2025 - 14:46 |
Lupus-Related Antibody Shows Promise in Enhancing Cancer Treatment Efficacy |
YaleUniversity |
Wed, 02/26/2025 - 04:33 |
Altering tumor microenvironment may reduce relapses after leukemia immunotherapy |
St Jude |
Thu, 02/20/2025 - 05:57 |
Chugai Obtains Regulatory Approval for Tecentriq for the Additional Indication of Alveolar Soft Part Sarcoma, an Ultra-rare Disease |
Chugai |
Mon, 02/17/2025 - 18:15 |
Radiation Plus Combination Immunotherapy May Help Preserve Bladder in Some Patients With Muscle-invasive Bladder Cancer |
American Associ... |
Mon, 02/17/2025 - 15:58 |
Some Kidney Cancer Patients Can Stop Combination Treatment After Two Years, Fox Chase Cancer Center Study Finds |
Fox Chase Cance... |
Tue, 02/11/2025 - 12:28 |
Two NFCR-Supported Researchers Help Identify Cells That Naturally Fight Cancer |
NFCR |
Tue, 02/04/2025 - 15:41 |
Preoperative immunotherapy could enhance breast cancer cure rates |
UTSouthwestern |
Fri, 01/24/2025 - 17:09 |
Fox Chase Cancer Center Researchers Present Data on Use of Checkpoint Inhibitors and Test Measuring Their Benefit to Patients |
Fox Chase Cance... |